The Scientific Leadership Council of the Pulmonary Hypertension Association

The scientific program of the Pulmonary Hypertension Association is guided by the association's Scientific Leadership Council. The Council includes the following health care professionals:

• Vallerie V. McLaughlin, MD, Chair, SLC, University of Michigan Health System, Ann Arbor, Michigan

• David B. Badesch, MD, SLC Immediate Past-Chair, University of Colorado Health Sciences Center, Aurora, Colorado

• John H. Newman, MD, SLC Vice-Chair, Vanderbilt Medical School, Nashville, Tennessee

• Raymond L. Benza, MD, Allegheny General Hospital, Pittsburgh, Pennsylvania

• Todd Bull, MD, University of Colorado Health Sciences Center, Denver, Colorado

• Richard Channick, MD, Editor-in Chief, Advances in Pulmonary Hypertension, UCSD Medical Center, La Jolla, California

• C. Gregory Elliott, MD, University of Utah School of Medicine, Murray, Utah

• Karen A. Fagan, MD, University of South Alabama, Mobile, Alabama

• Robert Frantz, MD, Mayo Clinic College of Medicine, Rochester, Minnesota

• John Granton, MD, Toronto General Hospital, Toronto, Canada

• Nicholas S. Hill, MD, Tufts-New England Medical Center, Boston, Massachusetts

• Marius Hoeper, MD, University of Hanover Medical School Hanover, Germany

• Dunbar Ivy, MD, University of Colorado Denver Health Sciences Center, Denver, Colorado

• Zhi-Cheng Jing, MD, Shanghai Pulmonary Hospital, Shanghai, China

• Anne M. Keogh, MD, St. Vincent's Public Hospital, Sydney, Australia

• Michael J. Krowka, MD, Mayo Clinic, Rochester, Minnesota

• James E. Loyd, MD, Vanderbilt University Medical Center, Nashville, Tennessee

• Michael Mathier, MD, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

• Michael D. McGoon, MD, Immediate Past-Chair, PHA Board of Trustees, Mayo Clinic, Rochester, Minnesota

• Srinivas Murali, MD, Allegheny General Hospital, Pittsburgh, Pennsylvania

• Ronald J. Oudiz, MD, Immediate Past Editor-in-Chief, Advances in Pulmonary Hypertension, Liu Center for Pulmonary Hypertension at Harbor – UCLA Medical Center, Torrance, California

• Andrew Peacock, MD, Western Infirmary, Glasgow, Scotland, United Kingdom

• Erika Berman Rosenzweig, MD, Editor-In-Chief Elect, Advances in Pulmonary Hypertension, Columbia Presbyterian Medical Center, New York, New York

• Ivan Robbins, MD, Chair, Scientific Sessions Committee, Vanderbilt University, Nashville, Tennesee

• Julio Sandoval, MD, National Institute of Cardiology of Mexico, Tlalpan, Mexico

• Richard Silver, MD, Medical University of South Carolina, Charleston, South Carolina

• Victor F. Tapson, MD, Duke University Medical Center, Durham, North Carolina

• Jason Yuan, MD, PhD, Chair, PHA Research Committee, University of California, San Diego, La Jolla, California

Liaisons

• Arlene Schiro, NP (voting), Chair, PH Resource Network, Massachusetts General Hospital, Boston, MA

• Harry Rozakis, Board Liaison

Emeritus Members

• Bruce H. Brundage, MD St. Charles Medical Center - Bend, Bend, Oregon

• Alfred P. Fishman, MD, University of Pennsylvania Health System, Philadelphia, Pennsylvania

The Mission of the Scientific Leadership Council is to provide medical and scientific guidance and support to the PHA by:

• Developing and disseminating knowledge for diagnosing and treating pulmonary hypertension

• Advocating for patients with pulmonary hypertension

• Increasing involvement of basic and clinical researchers and practitioners

More information on PHA's Scientific Leadership Council and associated committees can be found at: www.PHAssociation.org/SLC/